SCHEMBL3384574

SCHEMBL3384574

C#CCn1c(C)c(C)s/c1=N\C(=O)c1cc(Cl)ccc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.47
HPGD P15428 5/20 0.47
MAPT P10636 5/20 0.47
ALDH1A1 P00352 5/20 0.47
PPARG P37231 2/20 0.47
RAB9A P51151 2/20 0.47
NCOA2 Q15596 2/20 0.47
NCOA1 Q15788 2/20 0.47
NCOA3 Q9Y6Q9 2/20 0.47
PIM1 P11309 1/20 0.46
CLK2 P49760 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
POLB P06746 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
NPC1 O15118 2/20 0.45
PRNP P04156 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 1/20 0.45
PSMD14 O00487 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3384581 1.00 KDM4E (0.47) KDM4EHPGDMAPTALDH1A1PPARG
SCHEMBL3384552 0.84 PIM1 (0.63) KDM4EHPGDMAPTALDH1A1PIM1
SCHEMBL3384557 0.84 PIM1 (0.63) KDM4EHPGDMAPTALDH1A1PIM1
SCHEMBL945005 0.84 PIM1 (0.50) KDM4EHPGDMAPTALDH1A1PPARG
SCHEMBL945004 0.84 PIM1 (0.50) KDM4EHPGDMAPTALDH1A1PPARG
SCHEMBL3384387 0.84 PIM1 (0.46) KDM4EHPGDMAPTALDH1A1PPARG
SCHEMBL3384393 0.84 PIM1 (0.46) KDM4EHPGDMAPTALDH1A1PPARG
SCHEMBL13989602 0.83 CNR2 (0.61) PIM1CLK2CLK4CNR2CNR1
SCHEMBL3386996 0.79 PIM1 (0.42) KDM4EHPGDMAPTALDH1A1PIM1
SCHEMBL3386994 0.79 PIM1 (0.42) KDM4EHPGDMAPTALDH1A1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841334-B2 Compounds as cannabinoid receptor ligands and uses thereof ABBVIE INC. (US) 2014-09-23 US disclosed
EP-2222165-B1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF ABBVIE INC (US) 2013-07-31 EP disclosed
US-20100093814-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF ABBOTT LABORATORIES (US) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093814-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF CNR1, CNR2, OPRL1 KDM4E 2095/4885HPGD 2262/4885MAPT 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.